These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 7621437
1. Efficacy of photodynamic therapy against doxorubicin-resistant murine tumors. Canti G, Lattuada D, Morelli S, Nicolin A, Cubeddu R, Taroni P, Valentini G. Cancer Lett; 1995 Jul 13; 93(2):255-9. PubMed ID: 7621437 [Abstract] [Full Text] [Related]
2. Antitumor efficacy of the combination of photodynamic therapy and chemotherapy in murine tumors. Canti G, Nicolin A, Cubeddu R, Taroni P, Bandieramonte G, Valentini G. Cancer Lett; 1998 Mar 13; 125(1-2):39-44. PubMed ID: 9566694 [Abstract] [Full Text] [Related]
3. Antitumor immunity induced by photodynamic therapy with aluminum disulfonated phthalocyanines and laser light. Canti G, Lattuada D, Nicolin A, Taroni P, Valentini G, Cubeddu R. Anticancer Drugs; 1994 Aug 13; 5(4):443-7. PubMed ID: 7949249 [Abstract] [Full Text] [Related]
4. N-benzyladriamycin-14-valerate versus progressively doxorubicin-resistant murine tumours: cellular pharmacology and characterisation of cross-resistance in vitro and in vivo. Ganapathi R, Grabowski D, Sweatman TW, Seshadri R, Israel M. Br J Cancer; 1989 Dec 13; 60(6):819-26. PubMed ID: 2605093 [Abstract] [Full Text] [Related]
5. A fluorine-containing anthracycline (ME2303) as a new antitumor agent against murine and human tumors and their multidrug-resistant sublines. Tsuruo T, Yusa K, Sudo Y, Takamori R, Sugimoto Y. Cancer Res; 1989 Oct 15; 49(20):5537-42. PubMed ID: 2790778 [Abstract] [Full Text] [Related]
6. In vivo absorption spectrum of disulphonated aluminium phthalocyanine in a murine tumour model. Cubeddu R, Canti G, Musolino M, Pifferi A, Taroni P, Valentini G. J Photochem Photobiol B; 1996 Jul 15; 34(2-3):229-35. PubMed ID: 8810541 [Abstract] [Full Text] [Related]
7. In vitro and in vivo effects of photodynamic therapy on murine malignant melanoma. Haddad R, Blumenfeld A, Siegal A, Kaplan O, Cohen M, Skornick Y, Kashtan H. Ann Surg Oncol; 1998 Jul 15; 5(3):241-7. PubMed ID: 9607626 [Abstract] [Full Text] [Related]
8. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors. Garibjanian BT, Johnson RK, Kline I, Vadlamudi S, Gang M, Venditti JM, Goldin A. Cancer Treat Rep; 1976 Sep 15; 60(9):1347-61. PubMed ID: 797450 [Abstract] [Full Text] [Related]
9. Activity of SC33428, a novel bishydrazone-bridged derivative of 4-demethoxydaunorubicin, against experimental tumors in mice. Dawson KM. Cancer Res; 1983 Jun 15; 43(6):2880-3. PubMed ID: 6573953 [Abstract] [Full Text] [Related]
10. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice. Citarella RV, Wallace RE, Murdock KC, Angier RB, Durr FE, Forbes M. Cancer Res; 1982 Feb 15; 42(2):440-4. PubMed ID: 7055799 [Abstract] [Full Text] [Related]
18. In vivo antitumor activity of S 16020-2, a new olivacine derivative. Guilbaud N, Kraus-Berthier L, Saint-Dizier D, Rouillon MH, Jan M, Burbridge M, Visalli M, Bisagni E, Pierré A, Atassi G. Cancer Chemother Pharmacol; 1996 Feb 15; 38(6):513-21. PubMed ID: 8823492 [Abstract] [Full Text] [Related]